Bruno Carneiro De Medeiros, M.D. – FDA 483, Apr 29, 2016
An FDA inspection of Bruno C. de Medeiros, M.D. in Stanford, CA, revealed significant deficiencies in clinical trial conduct. The firm failed to maintain adequate and accurate case histories, including original source documents and proper informed consent. Additionally, investigations were not conducted according to the investigational plan, with issues such as failure to assess exclusion criteria, use of unapproved facilities, late SAE reporting, and incorrect study drug administration. Finally, investigational drug disposition records were inadequate, showing a substantial discrepancy in returned investigational product.
ID · 0bdc7016-1d72-44f2-99ef-b928ce85e84b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.